Loading data for PROK — first visit, this takes a few seconds.

ProKidney Corp. (PROK)

NasdaqCM: PROK · 실시간 가격 · USD

1.91

+0.06 (3.24%)

종가 기준: Sep 02, 2026, 8:00 PM

1.90

-0.45%

애프터마켓: 7:30 PM

알림

Alert

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

데이터 없음

매수호가	1.34
시가총액	762M
매출 (ttm)	818K
순이익 (ttm)	-84.2M
	1.72
	-0.55
	n/a
	-3.26
P/B (ttm)	-0.44
P/S (ttm)	932.08
실적 발표일	Nov 9, 2026

매도호가	2.4
거래량	629,392
평균 거래량 (20일)	1,212,866
시가	1.86
전일 종가	1.85
일중 범위	1.84 - 1.95
52주 범위	1.30 - 3.48
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

PROK 소개

ProKidney Corp., a clinical-stage biotechnology company, engages in the development of cell therapies for the treatment of chronic kidney diseases in the United States. The company develops rilparencel, a cell therapy with autologous selected renal cells, which is in Phase III clinical trial for the treatment of advanced chronic kidney disease and type 2 diabetes. It is also involved in the development of cryopreserved versions of rilparencel, in...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Jun 30, 2021

직원 수 231

상장 거래소 NasdaqCM

티커 PROK

웹사이트 https://prokidney.com

전체 기업 정보

재무 실적

2025년 ProKidney의 매출은 893K로, 전년 76K 대비 1,075% 증가했습니다. 순이익은 -68.99M로, 12.75% 증가했습니다.

재무제표

어닝 서프라이즈

ProKidney가 Aug 10, 2026에 분기 실적을 발표했습니다:

매출 $226K 예상치 하회 $0, 및 -1.74% 전년 대비 감소.
EPS -0.15 예상치 하회 -0.01, 및 -15.38% 전년 대비 감소.

다음 실적 발표

ProKidney Corp.의 실적 발표 예정일은 Nov 9, 2026, 정규장 중입니다.
애널리스트 예상 매출은 ... 업그레이드

주가가 움직인 이유

뉴스

3주 전 · Zacks

ProKidney Corp. (PROK) Reports Q2 Loss, Misses Revenue Estimates

PROKIDNEY CP (PROK) delivered earnings and revenue surprises of -15.39% and -31.82%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

2개월 전 · Insider Monkey

Why ProKidney (PROK) Is Building Its Bull Case Around Rilparencel’s Accelerated Approval Path

ProKidney Corp. (NASDAQ:PROK) is one of the small-cap stocks with potential to rise 1000 percent. The company’s main story centers on rilparencel, its experimental cell therapy for patients with advan...

3개월 전 · Simply Wall St.

Identiv And Two Other Penny Stocks To Watch Closely

The market remained flat over the last week, but it is up 26% over the past year, with earnings forecast to grow by 16% annually. For investors willing to look beyond the big names, penny stocks can p...

3개월 전 · Zacks

ProKidney Corp. (PROK) Reports Q1 Loss, Tops Revenue Estimates

PROKIDNEY CP (PROK) delivered earnings and revenue surprises of -7.69% and +222.86%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

3개월 전 · Zacks

ARS Pharmaceuticals, Inc. (SPRY) Reports Q1 Loss, Beats Revenue Estimates

ARS Pharmaceuticals, Inc. (SPRY) delivered earnings and revenue surprises of -15.09% and +2.01%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the st...

2 페이지 중 1

ProKidney Corp. (PROK)